Back

Survival after PCI or CABG for multivessel disease in NSTE-ACS: a report from the SWEDEHEART registry

31 August 2024 (14:47 - 15:00)
Organised by: Logo
Congress Presentation Part of: Registries, observational, and other studies on coronary disease including intervention and surgery Revascularisation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Elmir Omerovic

Sahlgrenska University Hospital, Gothenburg (Sweden)

5 More presentations in this session

Presentation thumbnail
Temporal trends in the use of drug-coated balloons
Professor R. Januszek (Krakow, PL)
Slides Video
Presentation thumbnail
Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials
Professor M. Valgimigli (Lugano, CH)
Slides Video
Presentation thumbnail
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Ms D. van Vliet (Enschede, NL)
Slides Video
Presentation thumbnail
Major adverse cardiovascular events, new diagnoses, prescription redemptions and outpatient visits in patients one year after evaluation for symptoms suggestive of chronic coronary syndrome
Doctor M. Bottcher (Aarhus, DK)
Slides Video
Presentation thumbnail
The trajectory of functional recovery after cardiac surgery: a prospective observational cohort study
Doctor J. Spence (Hamilton, CA)
Slides Video

Access the full session

Session thumbnail
Registries, observational, and other studies on coronary disease including intervention and surgery
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 14:47 CET
You may be interested in
thumbnail
Congress Session
Registries, observational, and other studies on coronary disease including intervention and surgery
thumbnail
Congress Session
Determinants of outcome following different coronary revascularisation approaches
thumbnail
Congress Presentation
Percutaneous coronary intervention and medical therapy versus medical therapy alone in chronic coronary syndrome: A hierarchical win-ratio analysis from SCAAR

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources